Assertio Holdings to be Acquired by Garda Therapeutics in a $125.1 Million Deal
Assertio Holdings, Inc. (ASRT) entered a merger agreement on April 8, 2026, to be acquired by Garda Therapeutics in a deal valued at $125.1 million. Deal Structure: Garda will…
Written byAsif SuriaSource: InsideArbitrage
Assertio Holdings, Inc. (ASRT) entered a merger agreement on April 8, 2026, to be acquired by Garda Therapeutics in a deal valued at $125.1 million. Deal Structure: Garda will commence a tender offer to acquire all outstanding shares of Assertio at an upfront price of $18 per share in cash, plus a non-tradeable CVR related